$JBS

JBS N.V.

CIK:0001791942|SEC Filings

Consolidated Statements of Income - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
Consolidated Statements of Income - USD ($) $ in Thousands	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Profit or loss [abstract]
NET REVENUE	$ 23,899,580	$ 20,997,656	$ 45,508,205	$ 40,524,176
Cost of sales	(21,311,679)	(18,165,135)	(40,595,716)	(35,067,104)
GROSS PROFIT	2,587,901	2,832,521	4,912,489	5,457,072
Selling expenses	(1,410,981)	(1,207,040)	(2,713,527)	(2,394,637)
General and administrative expenses	(588,125)	(522,284)	(1,143,749)	(1,078,711)
Other income	28,127	17,725	69,811	48,070
Other expenses	(19,813)	(15,842)	(43,428)	(43,799)
NET OPERATING EXPENSES	(1,990,792)	(1,727,441)	(3,830,893)	(3,469,077)
OPERATING PROFIT	597,109	1,105,080	1,081,596	1,987,995
Finance income	135,651	69,437	307,828	305,097
Finance expense	(831,223)	(445,841)	(1,317,609)	(873,047)
NET FINANCE EXPENSE	(695,572)	(376,404)	(1,009,781)	(567,950)
Share of profit of equity-accounted investees, net of tax	(123,621)	7,821	14,794	10,556
PROFIT BEFORE TAXES	(222,084)	736,497	86,609	1,430,601
Current income taxes	(18,101)	(165,666)	(51,871)	(390,457)
Deferred income taxes	144,010	23,483	110,677	110,504
TOTAL INCOME TAXES	125,909	(142,183)	58,806	(279,953)
NET INCOME	(96,175)	594,314	145,415	1,150,648
ATTRIBUTABLE TO:
Company shareholders	(102,109)	528,079	118,485	1,028,303
Non-controlling interest	5,934	66,235	26,930	122,345
NET INCOME	$ (96,175)	$ 594,314	$ 145,415	$ 1,150,648
Basic earnings per share - common shares (US$) (in Dollars per share)	$ (0.10)	$ 0.48	$ 0.11	$ 0.93
Diluted earnings per share - common shares (US$) (in Dollars per share)	$ (0.09)	$ 0.48	$ 0.11	$ 0.93

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities
Net income	$ 145,415	$ 1,150,648
Adjustments for:
Depreciation and amortization	1,256,587	1,100,838
Expected credit losses	4,959	13,258
Share of loss of equity-accounted investees	(14,794)	(10,556)
Gain on sales of assets	(13,261)	(8,880)
Tax expense	(58,806)	279,954
Net finance expense	1,009,781	567,950
Share-based compensation	25,762	14,116
Provisions for legal proceedings	72,988	15,565
Impairment of property, plant and equipment	22,624	13,613
Net realizable value inventory adjustments	31,995	20,419
DOJ (Department of Justice) and antitrust agreements	157,375	133,638
Fair value adjustment of biological assets	71,538	(86,487)
Provision for avian influenza	0	5,612
Net income and adjustments	2,712,163	3,209,688
Changes in assets and liabilities:
Trade accounts receivable	683,555	160,085
Inventories	(824,622)	(955,245)
Recoverable taxes	(19,460)	93,786
Other current and non-current assets	(88,222)	(362,166)
Biological assets	(415,776)	(398,066)
Trade accounts payable and supply chain finance	(437,706)	(575,413)
Taxes paid in installments	(23,039)	(51,896)
Other current and non-current liabilities	(294,141)	179,416
DOJ and Antitrust agreements payment/reimbursement	(98,767)	(261,212)
Income taxes paid	(400,299)	(550,897)
Changes in operating assets and liabilities	(1,918,477)	(2,721,608)
Cash from operating activities	793,686	488,080
Interest paid	(810,814)	(604,927)
Interest received	79,886	73,699
Net cash flows used in operating activities	62,758	(43,148)
Cash flow from investing activities
Purchases of property, plant and equipment	(1,178,902)	(714,122)
Dividends received	229	4,124
Purchase and disposals of intangible assets	(7,194)	(2,554)
Additions (disposals) to investments in joint ventures	26,352	(165,271)
Related party transactions	(16,750)	4,650
Proceeds from sale of property, plant and equipment	48,109	35,615
Cash used in investing activities	(1,128,156)	(837,558)
Cash flow from financing activities
Proceeds from loans and financings	3,865,514	4,494,204
Payments of loans and financings	(2,700,661)	(4,676,359)
Derivatives instruments received (settled)	(6,483)	(52,863)
Margin cash	(35,429)	(44,400)
Dividends paid	(1,039,099)	(1,573,855)
Dividends paid to non-controlling interest	(2,920)	(266,417)
Disposal of treasury shares	1,234	0
Payments of leasing contracts	(220,810)	(215,060)
Others	(2,768)	0
Cash used in financing activities	(141,422)	(2,334,750)
Effect of exchange rate changes on cash and cash equivalents	110,804	120,535
Net change in cash and cash equivalents	(1,096,016)	(3,094,921)
Cash and cash equivalents beginning of period	4,565,136	5,613,672
Cash and cash equivalents at the end of period	3,469,120	2,518,751
Non-cash additions to right of use assets and lease liabilities	206,473	153,798
Capitalized interests	24,046	$ 17,374
Closing of the bargaining gain calculation	$ (51,504)

Consolidated Statements of Financial Position - USD ($)	Jun. 30, 2026	Dec. 31, 2025
CURRENT ASSETS
Cash and cash equivalents	$ 3,469,120,000	$ 4,565,136,000
Margin cash	168,301,000	159,562,000
Trade accounts receivable	3,555,443,000	4,231,924,000
Dividends receivable	0	1,465,000
Inventories	6,996,200,000	6,107,165,000
Biological assets	1,810,275,000	1,826,766,000
Recoverable taxes	1,088,854,000	957,211,000
Derivative assets	118,170,000	155,602,000
Other current assets	550,408,000	433,372,000
TOTAL CURRENT ASSETS	17,756,771,000	18,438,203,000
NON-CURRENT ASSETS
Long-term investments	50,949,000	45,780,000
Recoverable taxes	2,085,715,000	1,874,572,000
Biological assets	660,066,000	611,799,000
Related party receivables	32,709,000	41,231,000
Deferred income taxes	656,067,000	547,014,000
Other non-current assets	563,888,000	488,803,000
Investments in equity-accounted investees	225,663,000	171,612,000
Property, plant and equipment	14,415,997,000	13,645,658,000
Right of use assets	1,621,847,000	1,613,647,000
Intangible assets	1,784,787,000	1,825,592,000
Goodwill	5,983,917,000	5,852,575,000
TOTAL NON-CURRENT ASSETS	28,081,605,000	26,718,283,000
TOTAL ASSETS	45,838,376,000	45,156,486,000
CURRENT LIABILITIES
Trade accounts payable	5,851,662,000	6,198,100,000
Supply chain finance	1,195,548,000	1,134,459,000
Loans and financing	1,334,897,000	833,085,000
Income taxes	122,923,000	288,030,000
Other taxes payable	187,613,000	152,959,000
Payroll and social charges	1,378,331,000	1,560,159,000
Lease liabilities	368,699,000	354,887,000
Dividends payable	117,000	0
Provisions for legal proceedings	220,431,000	159,217,000
Derivative liabilities	116,808,000	156,405,000
Other current liabilities	805,586,000	704,509,000
TOTAL CURRENT LIABILITIES	11,582,615,000	11,541,810,000
NON-CURRENT LIABILITIES
Loans and financing	21,315,792,000	20,257,483,000
Income and other taxes payable	424,436,000	407,727,000
Payroll and social charges	337,805,000	288,065,000
Lease liabilities	1,425,518,000	1,412,398,000
Deferred income taxes	1,175,082,000	1,169,300,000
Provisions for legal proceedings	223,544,000	209,358,000
Related party payables	142,536,000	190,998,000
Derivative liabilities	101,901,000	114,376,000
Other non-current liabilities	50,086,000	42,180,000
TOTAL NON-CURRENT LIABILITIES	25,196,700,000	24,091,885,000
EQUITY
Share capital - common shares	41,560,000	35,114,000
Reserves	8,064,257,000	6,582,694,000
Undistributed results	118,485,000	2,085,772,000
Attributable to company shareholders	8,224,302,000	8,703,580,000
Attributable to non-controlling interest	834,759,000	819,211,000
TOTAL EQUITY	9,059,061,000	9,522,791,000
TOTAL LIABILITIES AND EQUITY	$ 45,838,376,000	$ 45,156,486,000